Currently submitted to: JMIRx Med
Date Submitted: May 3, 2026
Open Peer Review Period: May 15, 2026 - Jul 7, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Clinical Integration of Wearable Biosensors and Patient-Generated Digital Data in Pediatric Cardiology: A Scoping Review
ABSTRACT
Background:
Wearable biosensors, remote physiologic monitoring, and patient-generated digital data are increasingly visible in pediatric cardiology, but their clinical use remains uneven. Pediatric cardiology clinics need practical guidance on which data streams have been studied, what clinical decisions they can support, and what safety, workflow, validation, and equity barriers must be addressed before routine integration.
Objective:
To map the literature on wearable biosensors and patient-generated digital data in pediatric cardiology and congenital heart disease, with emphasis on clinical applications, implementation pathways, validation, safety, and evidence gaps.
Methods:
A scoping review protocol was developed using the Population-Concept-Context framework and PRISMA-ScR reporting principles. Publicly accessible PubMed/MEDLINE, PubMed Central, and web-indexed searches were performed on May 3, 2026, with citation chasing of key background sources. Eligible records involved children, adolescents, young adults, or congenital heart disease populations and evaluated wearable biosensors, remote monitoring, mobile health tools, patient- or family-generated health data, or clinician-facing integration of digital data into pediatric cardiology workflows.
Results:
Thirty-five unique candidate records were screened. Twenty-two primary or clinically extractable records were mapped, with 11 additional background or source-mining records. Evidence clustered into single-ventricle interstage/home monitoring; high-risk congenital heart disease mobile health programs; telemedicine-linked monitoring; digital stethoscopes; smartwatch/mobile electrocardiography; cardiac implantable electronic device remote monitoring; and advanced wearable biomarker validation. The strongest clinical integration evidence was found in interstage single-ventricle monitoring and pediatric rhythm evaluation. Across categories, studies emphasized feasibility and diagnostic or workflow utility more often than long-term outcome effects, cost-effectiveness, interoperability, privacy, or equity.
Conclusions:
Wearable biosensors and patient-generated digital data are most clinically actionable in pediatric cardiology when linked to a predefined clinical question, validated data stream, responsible reviewer, escalation threshold, and documentation pathway. Current evidence supports selective use in interstage congenital heart disease monitoring, arrhythmia capture, remote device surveillance, and telecardiology adjuncts, but routine broad deployment requires stronger pediatric validation, workflow design, safety standards, and equity-focused implementation research.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.